STUDIER PÅ LEDDHELSE:
1. Effect of BioCell Collagen®, on Improving Joint Comfort: A Randomized, Double-Blind, Placebo-Controlled Trial.
Eighty subjects were divided into two groups and administered either 2 g of BioCell Collagen® supplement or placebo for ten weeks.
Compared to placebo, the BioCell group had a significant improvement of joint comfort on days 35 (p = 0.017) and 70 (p < 0.001).
BioCell group experienced a significant improvement in physical activities compared to the placebo group on days 35 (p = 0.007) and 70 (p < 0.001).
BioCell Collagen was well tolerated and found to be effective, thereby improving mobility and quality of life.
The peer-reviewed study was published in the Journal of
Agriculture and Food Chemistry. (https://pubs.acs.org/doi/10.1021/jf205295u) (Schauss et al., 2012).
Results of study – Min. 30% improvement in 71% of subjects taking BioCell Collagen
2. A Randomized Double-Blind Clinical Pilot Trial Evaluating the Safety and Efficacy of BioCell Collagen® in Adults for Joint Comfort
Sixteen subjects split evenly into two groups, ingested 1000 mg of BioCell Collagen® twice daily (2 g) or placebo for eight weeks.
As compared to the placebo group, the BioCell group showed 40% improvement
No adverse events associated with BioCell Collagen.
The study details were presented at the international conference of Experimental Biology, 2004, Washington, DC.
Results of the study – 40% improvement
3. BioCell Supplement on Subjective Discomfort (1999)
This 89 subject, prospective, crossover double-blind clinical study compared 2 g daily supplementation of the BioCell ingredient versus placebo over three months.
Out of the 89 participants who complained of subjective discomfort of various types, 80 of them (89%) reported some level of improvement within 45 days of taking the BioCell supplement.
In contrast, only one subject on placebo had improved.
No adverse events with the BioCell supplement. (1999 unpublished study)
Results of study – Effective in 89% of subjects
4. Effects of BioCell Collagen® on connective tissue protection and functional recovery from exercise in healthy adults.
In this pilot study, 3 g of BioCell Collagen supplement daily for six weeks enhanced recovery following weight training exercise and favorably impacted certain bio-markers of tendon and ligament connective tissue.
The study findings were published in the Journal of the International Society of Sports Nutrition (JISSN): http://www.jissn.com/content/11/S1/P48
STUDIER PÅ HUD:
1. Ingestion of BioCell Collagen®; enhanced blood microcirculation and reduced facial aging signs.
Twenty-six healthy female subjects aged 35 to 59 years of various ethnic origin.
Subjects ingested 1 g of BioCell Collagen® daily in two equally divided doses, morning and evening for 12 weeks.
BioCell Collagen® demonstrated the following results:
Significant reduction of facial lines and wrinkles
Significant reduction of facial skin dryness and scaling
Significant increase in facial dermal collagen content and microcirculation
The study findings are published in the journal of Clinical Interventions in Aging (2012).
(http://www.ncbi.nlm.nih.gov/pubmed/22956862)
2. BioCell Collagen® Improves Facial Epidermis and Connective Tissue in Healthy Adult Females: A Randomized, Double-Blind, Placebo-Controlled Trial..
One hundred thirteen healthy female subjects aged 39 to 59 years.
Subjects ingested 1 g of BioCell Collagen® daily in two equally divided doses, morning and evening for 12 weeks.
BioCell Collagen® demonstrated the following results compared to a placebo:
Significantly reduced facial lines and wrinkles (P = .019) and crow's feet lines and wrinkles (P = .05)
Significantly increased skin elasticity (P = .008) and cutaneous collagen content (P < .001) by 12%
Significantly improved indicators associated with a more youthful skin appearance based on visual grading and wrinkle width (P = .046)
Decreased skin dryness and erythema
The study findings are published in the journal of Alternative Therapies in Health and Medicine (2019).
(https://www.ncbi.nlm.nih.gov/pubmed/31221944)